Activation of the C3a–C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction
Basic Research in Cardiology · 28.04.2026 · 121 (3) · 481-502
DOI: 10.1007/s00395-026-01181-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 28.04.2026. Verfasst von Carl Vahldieck und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, University Medical Centre Schleswig-Holstein Campus Luebeck, Luebeck, Germany. carl.vahldie…. Hauptthemen laut MEDLINE: Glycocalyx, ST Elevation Myocardial Infarction, Endothelium, Vascular, Complement C3a. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung., Deutsche Forschungsgemeinschaft, Universität zu Lübeck.
Abstract (Originalsprache)
Complement activation is an early event in ischemia–reperfusion injury during ST-elevation myocardial infarction (STEMI) and drives endothelial dysfunction via glycocalyx (eGC) degradation. While downstream fragments such as C5a contribute to vascular injury, the role of the early anaphylatoxin C3a remains unclear. This study delineates the effects of the C3a:C3a-Receptor-axis on endothelial function, cytoskeletal dynamics, and eGC integrity. Sixty-four first-time STEMI patients and sixty-four age- and sex-matched healthy controls were enrolled. Patients were stratified into quartiles based on serum C3a concentrations, and comparisons were performed between the lowest vs. highest quartiles as well as between all STEMI patients vs. controls. Inflammatory and glycocalyx parameters were assessed via ELISA, AFM nanoindentation, and monocyte adhesion assays. NO bioavailability was measured chemiluminescence-based. C3a-receptor-antagonists (SB290157 and JR14a), C5a-Receptor1-antagonism (PMX53), as well as Rac1-Inhibition (NSC23766) were used to verify pathway specificity and downstream signaling involvement. High C3a levels were associated with marked endothelial injury: eGC height was reduced (− 44%; p < 0.001), cortical stiffness increased (+ 35%; p < 0.001), and shedding of Syndecan-1 and heparan sulfate was elevated (+ 203%, p < 0.001; + 181%, p < 0.01). NO bioavailability decreased by 34% (p < 0.05). C3a correlated inversely with eGC height (r = − 0.736) and positively with Syndecan-1 (r = 0.856). Treatment with recombinant C3a (250 ng/mL) induced cortical stiffening (+ 10.8%; p < 0.001), eGC loss (− 24.7%; p < 0.001), actin polymerization (+ 27.9%; p < 0.001), Rac1 activation (p < 0.05), reduced NO (− 38%; p < 0.05), and increased monocyte adhesion (+ 37%), all reversed by both C3a-Receptor-inhibitiors and by Rac1-inhibition. C3a:C3a-Receptor signaling drives Rac1-mediated cytoskeletal stiffening, eGC degradation, NO reduction, and leukocyte adhesion, promoting endothelial dysfunction in STEMI in both macrovascular and microvascular endothelial cells. This pathway represents a potential therapeutic target to mitigate complement-mediated vascular injury in acute myocardial infarction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, University Medical Centre Schleswig-Holstein Campus Luebeck, Luebeck, Germany. carl.vahldieck@uksh.de.
- Institute of Physiology, University of Luebeck, Luebeck, Germany. carl.vahldieck@uksh.de.
- DZHK (German Research Centre for Cardiovascular Research), Partner Site North, Luebeck, Germany. carl.vahldieck@uksh.de.
- Institute of Physiology, University of Luebeck, Luebeck, Germany.
- DZHK (German Research Centre for Cardiovascular Research), Partner Site North, Luebeck, Germany.
- Department of Cardiology, Medical Clinic II, Sana Kliniken Luebeck, Luebeck, Germany.
ORCID-Profile: Carl Vahldieck, Benedikt Fels, Kristina Kusche
Förderung
- Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
- Deutsche Forschungsgemeinschaft
- Universität zu Lübeck
Zitieren
APA
Vahldieck, C., Löning, S., Hamacher, C., Fels, B., Svensson, T., Rudzewski, B., Weil, J., & Kusche, K. (2026). Activation of the C3a–C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction. Basic Research in Cardiology, 121(3), 481-502. https://doi.org/10.1007/s00395-026-01181-w
Vancouver
Vahldieck C, Löning S, Hamacher C, Fels B, Svensson T, Rudzewski B, et al. Activation of the C3a–C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction. Basic Research in Cardiology. 2026;121(3):481-502. doi:10.1007/s00395-026-01181-w
BibTeX
@article{Vahldieck2026,
author = {Vahldieck, Carl and Löning, Samuel and Hamacher, Constantin and Fels, Benedikt and Svensson, Tanja and Rudzewski, Bettina and Weil, Joachim and Kusche, Kristina},
title = {Activation of the C3a–C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction},
journal = {Basic Research in Cardiology},
year = {2026},
volume = {121},
number = {3},
pages = {481--502},
doi = {10.1007/s00395-026-01181-w}
}
EUVIMED